MedPage Today on MSN
'Most compelling' data yet for metastasis-directed therapy in prostate cancer
But an association with improved overall survival failed to reach statistical significance ...
1) the active drug substance Axitinib, which used to belong to Pfizer, is an FDA-approved, oral, potent VEGFR inhibitor. So ...
Natalie Banner, Chief Ethics and Engagement Officer for Genomics England, shares how we can help to address inequities in ...
Q1 2026 earnings call highlights: record orders, margin expansion, raised EPS guidance to $4.70, and data center momentum.
Chalkbeat on MSN
This award-winning South Bronx teacher creates ‘living labs’ (and helps design Regents exams)
Bronx teacher Carolina Castro-Skehan discusses her journey from cosmetics to the classroom, her work on state Regents exams, ...
NHS patients will be told their real-time cancer risk with the help of gadgets such as smartwatches. Everyone will be able to ...
Researchers have published the recipe for an artificial-intelligence model that reviews the scientific literature better than ...
ScienceAlert on MSN
How Did This River 'Flow Uphill'? Geologists May Finally Have an Answer
For more than a century, the Green River's course through the Uinta Mountains in Utah's northeast has been a geological ...
Google fans can get their hands on freebies worth hundreds of pounds when they upgrade to a new Pixel phone. The deals are available at Currys-backed site Mobiles.co.uk, where customers will receive ...
Chinese NMPA approves Bayer’s oral ARi Nubeqa in combo with ADT for use in patients with metastatic hormone-sensitive prostate cancer: Berlin Wednesday, February 4, 2026, 14:00 ...
Keeping up with the latest research is vital for scientists, but given that millions of scientific papers are published every ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results